Hubei Cancer Hospital
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 763
- Cancer Immunotherapy and Biomarkers 159
- Lung Cancer Research Studies 115
- CAR-T cell therapy research 76
- Cancer Research 339
- Cancer-related molecular mechanisms research 127
- MicroRNA in disease regulation 78
Hubei Cancer Hospital
1.6k papers receiving 27.8k citations
Peers
Comparison fields: 5 of 208
- Cancer Research 5.7k
- Oncology 9.0k
- Molecular Biology 10.7k
- Immunology 3.3k
- Pulmonary and Respiratory Medicine 4.6k
Countries citing scholars working at Hubei Cancer Hospital
This map shows the geographic impact of research produced by authors working at Hubei Cancer Hospital. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Hubei Cancer Hospital with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubei Cancer Hospital more than expected).
Fields of papers published by authors at Hubei Cancer Hospital
This network shows the impact of papers affiliated with Hubei Cancer Hospital at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Hubei Cancer Hospital at the time of their publication.
About Hubei Cancer Hospital
In recent decades, authors affiliated with Hubei Cancer Hospital have published 1.8k papers, which have received a total of 28.1k indexed citations . Scholars at this organization have produced 763 papers in Oncology, 339 papers in Cancer Research, 437 papers in Pulmonary and Respiratory Medicine, 52 papers in Otorhinolaryngology and 203 papers in Radiology, Nuclear Medicine and Imaging on the topics of Cancer Immunotherapy and Biomarkers (159 papers), Lung Cancer Treatments and Mutations (151 papers), Cancer-related molecular mechanisms research (127 papers), RNA modifications and cancer (117 papers), Lung Cancer Research Studies (115 papers), Gastric Cancer Management and Outcomes (86 papers), MicroRNA in disease regulation (78 papers) and CAR-T cell therapy research (76 papers). Their work is cited by papers focused on Cancer Research (5.7k citations), Oncology (9.0k citations), Molecular Biology (10.7k citations), Immunology (3.3k citations) and Pulmonary and Respiratory Medicine (4.6k citations). Authors at Hubei Cancer Hospital collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Annals of Oncology, Frontiers in Oncology, Oncotarget and Medicine. Some of Hubei Cancer Hospital's most productive authors include Bin Xiong, Conghua Xie, Chaogang Yang, Sheng Hu, Melvin L.K. Chua, Shuyi Wang, Jing Yu, Wen Ouyang, Rongzhang Dou and Chu‐Bo Qi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.